Home
Search
Study Topics
Glossary
|
|
|
|
|
Sponsored by: |
NeuroSearch A/S |
---|---|
Information provided by: | NeuroSearch A/S |
ClinicalTrials.gov Identifier: | NCT00467428 |
The purpose of the study is to investigate if NS2359 is effective in the treatment of ADHD in adult patients.
Condition | Intervention | Phase |
---|---|---|
Attention Deficit Hyperactivity Disorder |
Drug: NS2359 Drug: Placebo |
Phase II |
Study Type: | Interventional |
Study Design: | Treatment, Randomized, Double-Blind, Placebo Control, Parallel Assignment, Safety/Efficacy Study |
Official Title: | Efficacy and Safety of NS2359 in Adults With Attention Deficit Hyperactivity Disorder. A Randomised, Double-Blind, Placebo-Controlled Study |
Enrollment: | 126 |
Study Start Date: | August 2003 |
Study Completion Date: | September 2004 |
Ages Eligible for Study: | 18 Years to 55 Years |
Genders Eligible for Study: | Both |
Accepts Healthy Volunteers: | No |
Inclusion Criteria:
Exclusion Criteria:
United States, Massachusetts | |
Adult and Pediatric Psychopharmacology, Massachusetts General Hospital | |
Boston, Massachusetts, United States, 02114 |
Principal Investigator: | Thimothy Wilens, MD | Adult and Pediatric Psychopharmacology, Masschusetts General Hospial, Boston, US |
Study ID Numbers: | NS2359-001 |
Study First Received: | April 27, 2007 |
Last Updated: | April 27, 2007 |
ClinicalTrials.gov Identifier: | NCT00467428 History of Changes |
Health Authority: | United States: Food and Drug Administration |
ADHD |
Signs and Symptoms Attention Deficit Disorder with Hyperactivity Mental Disorders Mental Disorders Diagnosed in Childhood |
Neurologic Manifestations Attention Deficit and Disruptive Behavior Disorders Hyperkinesis Dyskinesias |
Signs and Symptoms Pathologic Processes Disease Attention Deficit Disorder with Hyperactivity Mental Disorders Nervous System Diseases |
Mental Disorders Diagnosed in Childhood Neurologic Manifestations Attention Deficit and Disruptive Behavior Disorders Hyperkinesis Dyskinesias |